Cure My Disease

Don't miss your cure!

 Log in / Sign up

New vaccine combo aims to shrink tough liver tumors

NCT ID NCT05528952

Recruiting now Disease control Sponsor: Centre Hospitalier Universitaire de Besancon Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding an experimental cancer vaccine (UCPVax) to a standard immunotherapy drug combination (atezolizumab and bevacizumab) can better control advanced liver cancer that cannot be removed by surgery. It will involve about 105 adults with this type of cancer who have not yet received systemic treatment. The main goal is to see if more patients' tumors shrink with the vaccine combo compared to the standard drugs alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CH William Morey

    RECRUITING

    Chalon-sur-Saône, France

    Contact

  • CH de Mulhouse

    RECRUITING

    Mulhouse, France

    Contact

  • CHU de Besançon

    RECRUITING

    Besançon, France

    Contact

  • CHU de Montpellier

    RECRUITING

    Montpellier, France

    Contact

  • CHU de Poitiers

    NOT_YET_RECRUITING

    Poitiers, France

    Contact

  • Centre Georges François Leclerc

    RECRUITING

    Dijon, France

    Contact

  • Centre Hospitalier Paris St Joseph

    NOT_YET_RECRUITING

    Paris, France

    Contact

  • Groupe Hospitalier Paris Salpetrière

    RECRUITING

    Paris, France

    Contact

  • Hôpital BEAUJON

    RECRUITING

    Paris, France

    Contact

  • Hôpital Henri Mondor

    RECRUITING

    Créteil, France

    Contact

  • Hôpital Nord Franche-Comté

    RECRUITING

    Montbéliard, France

    Contact

  • Hôpital Paul Brousse

    RECRUITING

    Villejuif, France

    Contact

    Contact

  • Institut Mutualiste Montsouris

    RECRUITING

    Paris, France

    Contact

  • Institut de Cancérologie de l'Ouest

    NOT_YET_RECRUITING

    Nantes, France

    Contact

Conditions

Explore the condition pages connected to this study.

HEPATOCELLULAR CARCINOMA